91 related articles for article (PubMed ID: 2828388)
1. [Tumor markers in breast and endometrial cancer].
Garcia M; Maudelonde T
J Chir (Paris); 1987 Nov; 124(11):615-21. PubMed ID: 2828388
[TBL] [Abstract][Full Text] [Related]
2. Phage display derived human monoclonal antibodies isolated by binding to the surface of live primary breast cancer cells recognize GRP78.
Jakobsen CG; Rasmussen N; Laenkholm AV; Ditzel HJ
Cancer Res; 2007 Oct; 67(19):9507-17. PubMed ID: 17909061
[TBL] [Abstract][Full Text] [Related]
3. Development and evaluation of monoclonal antibody-based immunoassays: breast carcinoma-associated mucins as tumor markers.
Brown JP; Linsley PS; Horn D
Immunol Ser; 1990; 53():69-82. PubMed ID: 1713071
[No Abstract] [Full Text] [Related]
4. [Hormone receptors and tumor markers in cancer of the endometrium].
Hustin J; Franchimont P
J Gynecol Obstet Biol Reprod (Paris); 1988; 17(6):748-50. PubMed ID: 2850313
[No Abstract] [Full Text] [Related]
5. [Monoclonal antibodies in diagnosis of breast cancer].
Karsten U
Z Arztl Fortbild (Jena); 1991 Oct; 85(20):987-92. PubMed ID: 1776290
[No Abstract] [Full Text] [Related]
6. [Cell markers, hormone receptors and proliferation index in breast cancers. Role of immunodetection, image analysis and flow cytometry].
Charpin C; Habib MC; Andrac L; Vacheret H; Fraterno M; Lavaut MN; Toga M
Ann Pathol; 1989; 9(5):308-30. PubMed ID: 2558663
[No Abstract] [Full Text] [Related]
7. Aberrant expression of novel and previously described cell membrane markers in human breast cancer cell lines and tumors.
Huang H; Groth J; Sossey-Alaoui K; Hawthorn L; Beall S; Geradts J
Clin Cancer Res; 2005 Jun; 11(12):4357-64. PubMed ID: 15958618
[TBL] [Abstract][Full Text] [Related]
8. Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer.
Edwards DP; Grzyb KT; Dressler LG; Mansel RE; Zava DT; Sledge GW; McGuire WL
Cancer Res; 1986 Mar; 46(3):1306-17. PubMed ID: 3510721
[TBL] [Abstract][Full Text] [Related]
9. Human tetranectin: methodological and clinical studies.
Høgdall CK
APMIS Suppl; 1998; 86():1-31. PubMed ID: 9868384
[TBL] [Abstract][Full Text] [Related]
10. [Value of detection of hormone receptors by biochemical and immunochemical methods in therapeutic decision for breast cancer].
Goussard J
Bull Cancer; 1996 Dec; 83(12):1031-6. PubMed ID: 9116370
[TBL] [Abstract][Full Text] [Related]
11. Tissue distribution of breast cancer-associated antigens defined by monoclonal antibodies.
Frankel AE; Ring DB; Tringale F; Hsieh-Ma ST
J Biol Response Mod; 1985 Jun; 4(3):273-86. PubMed ID: 4020386
[TBL] [Abstract][Full Text] [Related]
12. [The place of tumor markers in breast and gynecologic neoplasms].
Gosselin P; Cazin JL; Demaille MC; Sulman C
Rev Fr Gynecol Obstet; 1988; 83(7-9):535-40. PubMed ID: 3057569
[TBL] [Abstract][Full Text] [Related]
13. Use of a monoclonal anti-estrogen receptor antibody in the immunohistochemical evaluation of human tumors.
McCarty KS; Szabo E; Flowers JL; Cox EB; Leight GS; Miller L; Konrath J; Soper JT; Budwit DA; Creasman WT
Cancer Res; 1986 Aug; 46(8 Suppl):4244s-4248s. PubMed ID: 3524805
[TBL] [Abstract][Full Text] [Related]
14. Expression of the CD44 glycoprotein (lymphocyte-homing receptor) in untreated human breast cancer and its relationship to prognostic markers.
de la Torre M; Heldin P; Bergh J
Anticancer Res; 1995; 15(6B):2791-5. PubMed ID: 8669866
[TBL] [Abstract][Full Text] [Related]
15. Monoclonal antibodies in the diagnosis and treatment of carcinoma of the breast.
Sterns EE; Cochran AJ
Surg Gynecol Obstet; 1989 Jul; 169(1):81-98. PubMed ID: 2662454
[TBL] [Abstract][Full Text] [Related]
16. RCAS1 is associated with ductal breast cancer progression.
Rousseau J; Têtu B; Caron D; Malenfant P; Cattaruzzi P; Audette M; Doillon C; Tremblay JP; Guérette B
Biochem Biophys Res Commun; 2002 May; 293(5):1544-9. PubMed ID: 12054692
[TBL] [Abstract][Full Text] [Related]
17. [Tumor markers in human breast cancer].
Takami H; Shikata J
Gan To Kagaku Ryoho; 1987 Nov; 14(11):2998-3003. PubMed ID: 3479050
[TBL] [Abstract][Full Text] [Related]
18. [Use of immunohistochemical markers in the diagnosis of carcinoma of the breast].
Bussolati G
Minerva Chir; 1988 Sep; 43(18 Suppl):5-7. PubMed ID: 3226595
[No Abstract] [Full Text] [Related]
19. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R
Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689
[TBL] [Abstract][Full Text] [Related]
20. Molecular basis of endocrine-responsive cancers.
Wittliff JL
Clin Physiol Biochem; 1987; 5(3-4):160-78. PubMed ID: 3621797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
